Health Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab) October 6, 2020
Health Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer October 5, 2020
Health 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions October 5, 2020
Search
